Decernotinib 5mg
Decernotinib is an oral, selective Janus kinase 3 (JAK3) inhibitor being developed by Vertex.
Trivial name | Decernotinib 5mg |
Catalog Number | A14012-5 |
Alternative Name(s) | (R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide |
Molecular Formula | C18H19F3N6O |
CAS# | 944842-54-0 |
SMILES | CC[C@](C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3 |
Size | 5mg |
Supplier Page | http://www.adooq.com/decernotinib.html |